The Sexually Transmitted Infections (STIs) Market in 2023 is US$ 62.79 billion, and is expected to reach US$ 162.5 billion by 2031 at a CAGR of 12.60%.
FutureWise Research published a report that analyzes Sexually Transmitted Infections (STIs) Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.
Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Sexually Transmitted Infections (STIs) research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.

Request a Sample Report @ Request for Sexually Transmitted Infections (STIs) Market Sample

Sexually Transmitted Infections (STIs) Market Segmentation:
By Location of Testing
• Laboratory Testing
• PCR
• Immunochromatographic assays
• Flow Cytometers
• Differential Light Scattering machines
• Enzyme Linked Immunosorbent Assay (ELISA)
• Point-of-care (POC) Testing
• Others
By Type
• HIV/AIDS
• Human Papilloma Virus (HPV)
• Gonorrhea
• Syphilis
• Others
By Treatment
• Antibiotics
• Antiviral
By Route of Administration
• Oral
• Parenteral
• Other
By End-Users
• Hospitals
• Specialty Clinics
• Homecare
• Others
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa
Key Market Players:
• Pfizer, Inc.
• GlaxoSmithKline plc
• Novartis AG
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Sanofi
• AstraZeneca.
• Johnson & Johnson Private Limited
• MerckCo., Inc.
• F. Hoffmann-La Roche Ltd.
• Bayer AG
• Eli Lilly and Company
• Sun Pharmaceutical Industries Ltd
• Aurobindo Pharma.
• Lupin
• Cipla Inc.
• Hologic, Inc.
• BD
• Bristol-Myers Squibb Company
• Gilead Sciences, Inc.
• Bausch Health Companies Inc.
Please visit full report of the Sexually Transmitted Infections (STIs) market @ Visit Sexually Transmitted Infections (STIs) Market
Competitive Landscape:
• Tier one players - market players with a significant share of the market
• Tier two players
• Players with rapid growth
• New Entries

FutureWise Key Takeaways:
• Prospects for growth
• Analysis of SWOT
• Key trends
• Key Data-points affecting market growth

Objectives of the Study:
• To provide report with an in-depth analysis of the Sexually Transmitted Infections (STIs) Market By Location of Testing, By Type, By Treatment, By Route of Administration, By End-Users, By Distribution Channel and By Region
• To offer data-points and comprehensive data on factors affecting the market (Opportunities, drivers, and industry-specific restraints)
• Analysis and forecasting of micro-markets, as well as the scope of the market.
• To predict the size and share, market forecast, in key regions — North America, Europe, Asia Pacific, and rest of the world
• To record and evaluate competition -mergers and expansions, product launches, and technological advancements within the market
Flexible Delivery Model:
• With our flexible delivery model, you will be able to suggest changes within the scope/table of content based on your requirement.
• Customization services are included with the purchase of any license type of report.
• Customization requests can be sent directly to: [email protected]

FutureWise Research:
Contact Person: Vinay T.
Email: [email protected]
Contact Number: UK: +44 1416289353 | US: +1 3477094931
Website: www.futurewiseresearch.com